Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer’s disease
Yan Li, Shuxian Lin, Zhicheng Gu, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 76, pp. 129015-129015
Closed Access | Times Cited: 23

Showing 23 citing articles:

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access | Times Cited: 2
Bee Pollen Phytochemicals and Nutrients as Unequaled Pool of Epigenetic Regulators: Implications for Age-Related Diseases
Rachid Kacemi, María G. Campos
Foods (2025) Vol. 14, Iss. 3, pp. 347-347
Open Access | Times Cited: 2
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretases
Miaomiao Zhang, Wanyao Wang, Qun Ye, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 15
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Rahul Patil, McKenzie E. Maloney, Rudolf Lucas, et al.
(2024)
Open Access | Times Cited: 5
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Rahul Patil, McKenzie E. Maloney, Rudolf Lucas, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 140-140
Open Access | Times Cited: 5
Hydrazides as Inhibitors of Histone Deacetylases
María do Carmo Carreiras, José Marco‐Contelles
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13512-13533
Closed Access | Times Cited: 5
Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment
Yi Zhang, Shasha Shen
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Re-exploration of tetrahydro-β-carboline scaffold: Discovery of selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting and neuroprotective activities
Wen Wen, Jiadong Hu, Chenxi Wang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 102, pp. 129670-129670
Closed Access | Times Cited: 4
Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities
Ting Liang, Zhao Xie, Baiyun Dang, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 81, pp. 129148-129148
Closed Access | Times Cited: 10
Anti-Alzheimer effects of an HDAC6 inhibitor, WY118, alone and in combination of lithium chloride: Synergistic suppression of ferroptosis via the modulation of tau phosphorylation and MAPK signaling
Zhonghui Lu, Zixing Jiang, Xiaoling Huang, et al.
European Journal of Pharmacology (2025), pp. 177605-177605
Closed Access
Butyrate: a key mediator of gut-brain communication in Alzheimer’s disease
Faeze Kachoueiyan, Niosha Yahyavi Kalkhoran, Anousha Yahyavi Kalkhoran, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 5
Closed Access
Therapeutic Potential of Dual HDAC6/SIRT2 Inhibition in Alzheimer’s Disease
Xingyu Wang, Cunjiang Li, Lei Chen, et al.
European Journal of Medicinal Chemistry (2025) Vol. 294, pp. 117733-117733
Closed Access
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease
Alan Santini, Elisa Tassinari, Eleonora Poeta, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 11, pp. 2099-2111
Closed Access | Times Cited: 3
N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity
Dimitrios Triantafyllos Gerokonstantis, Christiana Mantzourani, Dimitrios Gkikas, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 14357-14376
Closed Access | Times Cited: 8
Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6
P. R. Watson, Suchetana Gupta, Parisa Hosseinzadeh, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 959-968
Open Access | Times Cited: 6
HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry
S. Rajaraman, Ranjani Balakrishnan, Dhruv Deshmukh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 885-908
Closed Access | Times Cited: 6
Transcriptome analysis identifies the role of Class I histone deacetylase in Alzheimer’s disease
Fan Geng, Na Zhao, Chen Xiu, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18008-e18008
Open Access | Times Cited: 6
Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer’s Disease
L. O. Bryzgalov, Elena E. Korbolina, Т. И. Меркулова
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7955-7955
Open Access | Times Cited: 5
Hydrazides as Potential HDAC Inhibitors: Structure-activity Relationships and Biological Implications
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 25, pp. 2343-2372
Closed Access | Times Cited: 4
Transcriptome-wide association study of Alzheimer disease reveals many differentially expressed genes and multiple biological pathways in brain tissue from African American donors
Mark W. Logue, Adam Labadorf, Nicholas K. O’Neill, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the Alzheimer's disease mouse model by regulating the expression of App secretases
Miaomiao Zhang, Wanyao Wang, Qun Ye, et al.
Research Square (Research Square) (2023)
Open Access
Histone Deacetylase Inhibitors: Design, Synthesis, and Biological Evaluation
Sravani Pulya, Abhiram Ganorkar, Swati Biswas, et al.
(2023), pp. 427-447
Closed Access
Page 1

Scroll to top